CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
HPV-associated lung cancers: An international pooled analysis
Authors
C. Ragin Obikoya-Malomo, M. Kim, S. Chen, Z. Flores-Obando, R. Gibbs, D. Koriyama, C. Aguayo, F. Koshiol, J. Caporaso, N.E. Carpagnano, G.E. Ciotti, M. Dosaka-Akita, H. Fukayama, M. Goto, A. Spandidos, D.A. Gorgoulis, V. Heideman, D.A.M. van Boerdonk, R.A.A. Hiroshima, K. Iwakawa, R. Kastrinakis, N.G. Kinoshita, I. Akiba, S. Landi, M.T. Liu, H. Wang, J.-L. Mehra, R. Khuri, F.R. Lim, W.-T. Owonikoko, T.K. Ramalingam, S. Sarchianaki, E. Syrjanen, K. Tsao, M.-S. Sykes, J. Hee, S.W. Yokota, J. Zaravinos, A. Taioli, E.
Publication date
1 January 2014
Publisher
Abstract
Human papillomavirus (HPV) is the etiologic risk factor for cervical cancer. Some studies have suggested an association with a subset of lung tumors, but the etiologic link has not been firmly established. We performed an international pooled analysis of crosssectional studies (27 datasets, n = 3249 patients) to evaluate HPV DNA prevalence in lung cancer and to investigate viral presence according to clinical and demographic characteristics. HPV16/18 were the most commonly detected, but with substantial variation in viral prevalence between geographic regions. The highest prevalence of HPV16/18 was observed in South and Central America, followed by Asia, North America and Europe (adjusted prevalence rates = 22, 5, 4 and 3%, respectively). Higher HPV16 prevalence was noted in each geographic region compared with HPV18, except in North America. HPV16/18-positive lung cancer was less likely observed among White race (adjusted odds ratio [OR] = 0.33, 95% confidence interval [CI] = 0.12-0.90), whereas no associations were observed with gender, smoking history, age, histology or stage. Comparisons between tumor and normal lung tissue show that HPV was more likely to be present in lung cancer rather than normal lung tissues (OR = 3.86, 95% CI = 2.87-5.19). Among a subset of patients with HPV16-positive tumors, integration was primarily among female patients (93%, 13/14), while the physical status in male cases (N = 14) was inconsistent. Our findings confirm that HPV DNA is present in a small fraction of lung tumors, with large geographic variations. Further comprehensive analysis is needed to assess whether this association reflects a causal relationship. © The Author 2014. Published by Oxford University Press. All rights reserved
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3087849
Last time updated on 10/02/2023